PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS
Abstract. Pyrazinamide (PZA) is unique in that it is a component of the first line therapy for drug sensitive tuberculosis and in most current and experimental treatments also for multi drug resistant tuberculosis. Furthermore, PZA has been shown to help to ensure lasting cure and prevent relapse in...
Guardado en:
Autores principales: | R. M. Anthony, A. L. den Hertog |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f1887f2eca534864a7aa89f5d09b7057 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Detección de mutaciones asociadas a cepas multidrogo resistente de Mycobacterium tuberculosis en Chile
por: Araya,Pamela, et al.
Publicado: (2011) -
Behçet’s disease with latent Mycobacterium tuberculosis infection
por: Shen Yan, et al.
Publicado: (2020) -
THE GROWTH RATE PHENOTYPIC PROPERTY OF MYCOBACTERIUM TUBERCULOSIS CLINICAL STRAINS: DEPENDENCE ON TUBERCULOSIS LOCALIZATION, TREATMENT, DRUG SUSCEPTIBILITY
por: O. A. Manicheva, et al.
Publicado: (2018) -
DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN DIFFERENT LOCALIZATIONS OF THE DISEASE
por: P. K. Yablonskii, et al.
Publicado: (2016) -
Combination of HLA-DR on Mycobacterium tuberculosis-Specific Cells and Tuberculosis Antigen/Phytohemagglutinin Ratio for Discriminating Active Tuberculosis From Latent Tuberculosis Infection
por: Ying Luo, et al.
Publicado: (2021)